Publisher
Springer Science and Business Media LLC
Reference173 articles.
1. Nichols, D. E. Psychedelics. Pharmacol. Rev. 68, 264–355 (2016).
2. Yaden, D. B., Mathai, D., Bogenschutz, M. & Nichols, D. in The ASAM Principles of Addiction Medicine 7th edn (eds. Miller, S. C. et al.) 269–292 (Wolters Kluwer, 2024).
3. Barrett, F. S., Johnson, M. W. & Griffiths, R. R. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J. Psychopharmacol. 29, 1182–1190 (2015).
4. Griffiths, R. R. et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J. Psychopharmacol. 32, 49–69 (2018).
5. Studerus, E., Gamma, A. & Vollenweider, F. X. Psychometric evaluation of the Altered States of Consciousness Rating Scale (OAV). PLoS ONE 5, e12412 (2010).